KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Payables (2016 - 2025)

Historic Payables for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $130.3 million.

  • Bio-Rad Laboratories' Payables rose 550.61% to $130.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $130.3 million, marking a year-over-year increase of 550.61%. This contributed to the annual value of $130.3 million for FY2025, which is 550.61% up from last year.
  • According to the latest figures from Q4 2025, Bio-Rad Laboratories' Payables is $130.3 million, which was up 550.61% from $130.1 million recorded in Q3 2025.
  • In the past 5 years, Bio-Rad Laboratories' Payables ranged from a high of $161.5 million in Q1 2023 and a low of $103.2 million during Q1 2024
  • Over the past 5 years, Bio-Rad Laboratories' median Payables value was $138.6 million (recorded in 2021), while the average stood at $137.0 million.
  • In the last 5 years, Bio-Rad Laboratories' Payables plummeted by 7574.61% in 2021 and then skyrocketed by 3473.85% in 2025.
  • Over the past 5 years, Bio-Rad Laboratories' Payables (Quarter) stood at $142.4 million in 2021, then decreased by 4.86% to $135.5 million in 2022, then increased by 7.08% to $145.1 million in 2023, then dropped by 14.89% to $123.5 million in 2024, then rose by 5.51% to $130.3 million in 2025.
  • Its last three reported values are $130.3 million in Q4 2025, $130.1 million for Q3 2025, and $140.6 million during Q2 2025.